Herb World News Online

Herb Research Foundation


 Top News  |  World  |  Science  |  Research Reviews  |  Politics  |  Industry  |  Features
 Industry News

Clinical study on feverfew supplement announced by Kaiser-Permanente

The double blind, placebo-controlled study will evaluate the effectiveness of Migra-LieveTM on migraine frequency and severity over a three month period. Developed by Natural Science Corporation of America, Migra-LieveTM is a patent pending combination of magnesium, riboflavin, and a proprietary standardized extract of feverfew. The product is marketed to physicians and pharmacists, and is currently being used by a number of doctors, hospitals, and clinics, including the New York Headache Center in New York City.

PR Newswire, January 26, 2000.

 Top News  |  World  |  Science  |  Research Reviews  |  Politics  |  Industry  |  Features

Back to the Herb World News Online Front Page

Visit the Herb World News Archives

© 2003 by Herb Research Foundation, Boulder, CO, USA.

Main Page